Table 2.

Documented Use of Evidence-Based Cessation Treatment in Pooled Intervention and Usual Care Groups

	Pooled intervention groups* (n = 157)	Usual care group (n = 76)	P value
Any evidence-based tobacco cessation treatment	99 (63.1%)	26 (34.2%)	< 0.001
Use of both evidence-based tobacco cessation counseling and medication	56 (35.7%)	4 (5.3%)	< 0.001
Any counseling	73 (46.5%)	7 (9.2%)	< 0.001
In-person counseling at MGH Health Center	21 (13.4%)	7 (9.2%)	0.36
Telephone counseling by Quitline	44 (28.0%)	0 (0%)	< 0.001
Telephone counseling by MGH Tobacco Care Coordinator	29 (18.5%)b	–†	–
Any medication	82 (52.2%)	23 (30.3%)	0.002
Nicotine replacement therapy (any)	72 (45.9%)	18 (23.7%)	0.001
Nicotine patch	40 (25.5%)	15 (19.7%)	0.33
Nicotine lozenge	12 (7.6%)	5 (6.6%)	0.77
Nicotine gum	14 (8.9%)	2 (2.6%)	0.08
Nicotine inhaler	12 (7.6%)	1 (1.3%)	0.07
Bupropion	16 (10.2%)	8 (10.5%)	0.94
Varenicline	16 (10.2%)	4 (5.3%)	0.21

*Includes 79 participants in the internal care coordination group and 78 participants in the external community referral group

^†Only participants in the internal care coordination group had access to the MGH Tobacco Coordinator